Brain Cancer Clinical Trials in Los Angeles

Showing 101-120 of 136 trials

First in Patient Study for PF-06840003 in Malignant Gliomas

NCT02764151

This study will evaluate the safety and tolerability of increasing doses of PF-06840003 in patients with malignant gliomas.

OligodendrogliomaAstrocytomaMalignant Glioma

Pfizer17 participantsStarted Sep 2016

Los Angeles, California, United States • Los Angeles, California, United States • Los Angeles, California, United States +11 more locations

COMPLETEDPhase 2< 1 mile

Radiation Therapy in Treating Young Patients With Gliomas

NCT00238264

RATIONALE: Specialized radiation therapy that delivers radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue. PURPOSE: This phase II trial is studying how well radiation therapy works in treating young patients with gliomas.

Brain TumorCentral Nervous System Tumor

Children's Oncology Group92 participantsStarted Nov 2006

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Little Rock, Arkansas, United States +142 more locations

First in Patient Study for PF-06840003 in Malignant Gliomas

Radiation Therapy in Treating Young Patients With Gliomas

Brain Cancer Trials in Other Cities

Tumor Lysate Pulsed Dendritic Cell Immunotherapy for Patients With Brain Tumors

Radiation Therapy Compared With Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Primary Central Nervous System (CNS) Germ Cell Tumor

A Study of ICT-121 Dendritic Cell Vaccine in Recurrent Glioblastoma

Imetelstat Sodium in Treating Younger Patients With Recurrent or Refractory Brain Tumors

Erlotinib in Treating Patients With Recurrent Malignant Glioma or Recurrent or Progressive Meningioma

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

A Study of MEDI-575 in Subjects With Recurrent Glioblastoma Multiforme

Pazopanib in Treating Patients With Recurrent Glioblastoma

Assessing the Suitability of an Imaging Probe for Use in Clinical Cell and Gene Therapy Trials in Cancer and Rheumatoid Arthritis

A Study of GDC-0084 in Patients With Progressive or Recurrent High-Grade Glioma

Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors

AMG 595 First-in-Human in Recurrent Gliomas

Bevacizumab and Irinotecan or Temozolomide in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme or Gliosarcoma

Expanded Access to ANG1005 for Individual Patients

A Study Combining LY2157299 With Temozolomide-based Radiochemotherapy in Patients With Newly Diagnosed Malignant Glioma

Bevacizumab and Irinotecan in Treating Young Patients With Recurrent, Progressive, or Refractory Glioma, Medulloblastoma, Ependymoma, or Low Grade Glioma

AZD2171 in Treating Young Patients With Recurrent, Progressive, or Refractory Primary CNS Tumors

Everolimus (RAD001) for Children With Chemotherapy-Refractory Progressive or Recurrent Low-Grade Gliomas

Other Conditions in Los Angeles